Poging GOUD - Vrij
BioNTech Acquires CureVac for $1.2 Billion to Boost Cancer Biz
Mint Kolkata
|June 13, 2025
BioNTech SE has agreed to buy former COVID vaccine rival CureVac NV for about $1.25 billion in an all-stock transaction to boost its growing oncology business.
CureVac investors will get around $5.46 in BioNTech shares for each CureVac one, the companies said Thursday. The price represents a 34% premium to CureVac's closing share price on Wednesday.
CureVac shareholders will own 4% to 6% of BioNTech once the transaction closes. The deal caps decades of rivalry, which came to a head during the race to develop a COVID vaccine. BioNTech had won the race with its partner Pfizer Inc., to transform into one of Europe's leading biotechs. CureVac's shot never made it to the market after proving less effective in clinical trials.
Dit verhaal komt uit de June 13, 2025-editie van Mint Kolkata.
Abonneer u op Magzter GOLD voor toegang tot duizenden zorgvuldig samengestelde premiumverhalen en meer dan 9000 tijdschriften en kranten.
Bent u al abonnee? Aanmelden
MEER VERHALEN VAN Mint Kolkata
Mint Kolkata
The dollar is far from dead and the yuan is not staging a coup
Greenback doomsayers got it wrong. The dollar's reign is not over
3 mins
October 10, 2025
Mint Kolkata
Sebi's Ananth Narayan steps down
Narayan headed market regulation and the department dealing with foreign investors.
1 min
October 10, 2025
Mint Kolkata
Corporate governance needs to go well beyond mere compliance
Shareholders now demand more than mere regulatory compliance to monitor the governance of companies they partly own
3 mins
October 10, 2025
Mint Kolkata
Intel unveils new tech in turnaround push
Intel Corp., the embattled chipmaker now backed by the US government, introduced new products and manufacturing technology that are central to its turnaround bid.
1 min
October 10, 2025
Mint Kolkata
Shipbuilding stocks are likely to stay anchored
India's shipbuilding stocks are trading well above their 200-day moving average, a sign of rising investor confidence.
3 mins
October 10, 2025
Mint Kolkata
Silver ETFs fired up by scarcity, festivals
Silver exchange traded funds or ETFs opened Thursday with a record 10-12% premium to spot prices, underscoring a scramble for the metal as festive buying, industrial use, and investor FOMO (fear of missing out) drove up demand against tight supplies.
1 min
October 10, 2025
Mint Kolkata
Go First files plea against Air Works
Bankrupt airline Go First has filed a fresh plea before the National Company Law Tribunal (NCLT), Delhi, seeking the release and disclosure of several aircraft components, primarily small tyres and wheels, that it claims are being withheld by maintenance, repair and overhaul (MRO) firm Air Works India (Engineering) Pvt. Ltd, a subsidiary of the Adani Group.
1 min
October 10, 2025
Mint Kolkata
Nestlé looks beyond Maggi, bets on India petcare boom
Nestlé SA sees India as a potential top-three global petcare market after the US and China
2 mins
October 10, 2025
Mint Kolkata
Tax residency depends on your travel pattern and primary base
I am a salaried individual employed by an Indian company that allows me to work remotely. I get paid in India. My spouse lives abroad, so I frequently travel outside the country. Over the last two years, I have spent at least three months each year in India.
2 mins
October 10, 2025
Mint Kolkata
It is time to strengthen India-Afghanistan ties
An Afghan minister's visit right after New Delhi joined hands with other countries to rebuff America's eyeing of Bagram offers us a chance to re-imagine the regional balance of power
2 mins
October 10, 2025
Listen
Translate
Change font size